ClinicalMetric / Countries / Netherlands
← All Countries
🇳🇱
COUNTRY FEED

Clinical Trials in Netherlands

Active recruiting clinical trials with sites in Netherlands. Select a condition below to see detailed trial listings.

Total Trials: 194 // Recruiting: 194 // Updated: Daily

Netherlands currently has 194 clinical trials with at least one registered site in the country, of which 194 are actively recruiting participants. The most studied conditions at Netherlands sites are Obesity, Prostate Cancer, Breast Cancer, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including University Medical Center Groningen, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Erasmus Medical Center. By stage, active Netherlands trials break down as Phase 1 (16), Phase 2 (19), Phase 3 (17), Phase 4 (8). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Netherlands

Obesity 5 Prostate Cancer 4 Breast Cancer 4 Glioblastoma 3 Cervical Cancer 3 Type 2 Diabetes 3 Osteoarthritis, Hip 3 Parkinson Disease 3 Cancer 3 Pancreatic Cancer 2 Adult Congenital Heart Disease 2 Congenital Heart Disease 2 Coronary Artery Disease 2 Quality of Life 2 Steatosis of Liver 2 Metabolic Syndrome 2 Tricuspid Regurgitation 2 Atrial Fibrillation 2 COPD 2 Proton Therapy 2
All Countries → All Trials →

Other Countries in This Region

🇬🇷Greece 🇩🇪Germany 🇫🇷France 🇮🇹Italy 🇪🇸Spain 🇬🇧United Kingdom 🇧🇪Belgium 🇵🇱Poland 🇸🇪Sweden 🇦🇹Austria
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology